Neobiomics and ProPrems®Neobiomics is an innovation-driven startup company in Sweden. Our first project is ProPrems®, a dietary supplement product for children to support the intestinal microbiota. What we needWe now need to extend our team with a project coordinator who is able to take on a large variety To-Do’s within the ProPrems® project: manage pre-orders…
Although somewhat prematurely* 😉 we will launch ProPrems® at the 99nicu Meetup Future of Neonatal Care, at Scandic Sluseholmen in Copenhagen. The mini symposium will take place Monday 8/4, right after the lecture program ends at 17:00. The distinguished speakers include: Adam Baker, Chr. Hansen Marijn J Vermeulen, Erasmus University Medical Center Stefan Johansson, CEO…
Neobiomics is granted a first startup loan from Almi. We are mostly grateful for the loan from Almi. Although only a smaller startup loan, those funds will be essential for the launch of ProPrems® during 2019. Furthermore, Almi also gives invaluable support in our discussions how to set up our business and to get startup…
Neobiomics now recieves support from KI Innovations. We are more than grateful and also proud that KI Innovations sees the potential in our projects. The support makes us even more dedicated to succeed. KI Innovations is an incubator and a wholly owned subsidiary of Karolinska Institutets holding company. KI Innovations utilises research findings in life…
We are now residing on a .eu domain, i.e. the URL to the web site is changed to neobiomics.eu and all our email addresses are @neobiomics.eu. This change adjusts the contextual frame for Neobiomics. An .eu domain will not only accommodate our European roots, but also signal that Neobiomics is not just like any other company.
